Qinecsa COO, John Cogan, has been featured in European Pharmaceutical Manufacturer‘s latest article, where he discusses AI’s pivotal role in powering the pharmacovigilance engine. As
Molecule to Market is a podcast focused on the pharmaceutical and biotech industries, particularly the outsourcing and supply chain side of drug development. Hosted by Raman
Download the whitepaper now to discover how Qinecsa can help your organization streamline pharmacovigilance operations while maximizing compliance and ROI.
Why an AI Enhanced Approach to Pharmacovigilance Case Processing is now Non-negotiable Qinecsa CEO, Adam Sherlock has been featured in Simedics (The Journal of mHealth)
04 April 2022, London – Qinecsa Solutions announced the acquisition of MyMeds&Me Limited (MMM). Qinecsa, a leading provider of pharmacovigilance services and technologies to the global pharmaceutical industry.
21th March 2024 —Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, proudly announce its acquisition of Insife ApS (Insife), a well-established Danish-based software, technology, and consultancy firm specializing in developing revolutionary pharmacovigilance platforms. This acquisition is in alignment with Qinecsa’s vision, playing a crucial role in the company’s pursuit to become the leading provider of digital pharmacovigilance solutions.
15 December 2022, London – Qinecsa Solutions UK Ltd. (Qinecsa) has announced the acquisition of Commonwealth Informatics, Inc. (Commonwealth). Qinecsa, a leading provider of pharmacovigilance services and technologies to the global pharmaceutical industry.
GRIP – A better way to manage PV Regulatory Intelligence Webinar This webinar about GRIP (Global Regulatory Intelligence Platform) focuses on providing a more efficient
Webinar: HaloPV 6.0 One unique solution for all your PV system needs The HALOPV 6.0 webinar on December 5, 2024, showcased the platform’s latest features,
We’re proud to be featured in Applied Clinical Trials’ latest article spotlighting the future of pharmacovigilance: “Harnessing Technology and Adopting Unified Approaches to Optimize Pharmacovigilance
2 Leman Street,
London, E1W 9US
United Kingdom
Company number: 13916274
